Synopsis
0
JDMF
0
EU WC
0
KDMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
71
PharmaCompass offers a list of Levamisole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levamisole manufacturer or Levamisole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levamisole manufacturer or Levamisole supplier.
PharmaCompass also assists you with knowing the Levamisole API Price utilized in the formulation of products. Levamisole API Price is not always fixed or binding as the Levamisole Price is obtained through a variety of data sources. The Levamisole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vermisol 150 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vermisol 150, including repackagers and relabelers. The FDA regulates Vermisol 150 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vermisol 150 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vermisol 150 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vermisol 150 supplier is an individual or a company that provides Vermisol 150 active pharmaceutical ingredient (API) or Vermisol 150 finished formulations upon request. The Vermisol 150 suppliers may include Vermisol 150 API manufacturers, exporters, distributors and traders.
click here to find a list of Vermisol 150 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vermisol 150 DMF (Drug Master File) is a document detailing the whole manufacturing process of Vermisol 150 active pharmaceutical ingredient (API) in detail. Different forms of Vermisol 150 DMFs exist exist since differing nations have different regulations, such as Vermisol 150 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vermisol 150 DMF submitted to regulatory agencies in the US is known as a USDMF. Vermisol 150 USDMF includes data on Vermisol 150's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vermisol 150 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vermisol 150 suppliers with USDMF on PharmaCompass.
A Vermisol 150 CEP of the European Pharmacopoeia monograph is often referred to as a Vermisol 150 Certificate of Suitability (COS). The purpose of a Vermisol 150 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vermisol 150 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vermisol 150 to their clients by showing that a Vermisol 150 CEP has been issued for it. The manufacturer submits a Vermisol 150 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vermisol 150 CEP holder for the record. Additionally, the data presented in the Vermisol 150 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vermisol 150 DMF.
A Vermisol 150 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vermisol 150 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vermisol 150 suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vermisol 150 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vermisol 150 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vermisol 150 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vermisol 150 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vermisol 150 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vermisol 150 suppliers with NDC on PharmaCompass.
Vermisol 150 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vermisol 150 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vermisol 150 GMP manufacturer or Vermisol 150 GMP API supplier for your needs.
A Vermisol 150 CoA (Certificate of Analysis) is a formal document that attests to Vermisol 150's compliance with Vermisol 150 specifications and serves as a tool for batch-level quality control.
Vermisol 150 CoA mostly includes findings from lab analyses of a specific batch. For each Vermisol 150 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vermisol 150 may be tested according to a variety of international standards, such as European Pharmacopoeia (Vermisol 150 EP), Vermisol 150 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vermisol 150 USP).
